Advisory Board
The RECNACTM Scientific Advisory Board is comprised of several leading highly qualified international cancer research experts as follows:
- Gary Stoner, PhD: Professor Emeritus, Division of Hematology and Oncology, Department of Internal Medicine; Professor of Pathology, Ohio State University College of Medicine; also Director of the Laboratory of Cancer Chemoprevention and Etiology, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Previously Director of the Chemoprevention Program, Chair of the Division of Environmental Health Sciences, Associate Dean for Research, and Co-Director of the Center for Molecular and Environmental Health, Ohio State. Served as the Chair of the American Cancer Society's Carcinogenesis, Nutrition and Environment Advisory Committee, and Chair of the Chemo/Dietary Prevention Study Section at the National Institutes of Health and the National Cancer Institute
- Michael Burke, M.D.: Immunologist; Director, Clinical Immunology Unit, Sourasky Medical Center (1990-2008); former faculty member Sackler School of Medicine and Harvard Medical School
- Solomon Wasser, PhD, DSc: Professor of Mycology and Botany, Univ. of Haifa; Chairman, Dept. of Cryptogrammic Plants, Kholodny Institute, National Academy of Sciences, Ukraine; Founder and Editor in Chief of the International Journal of Medicinal Mushrooms
- Donald Wayne Aaronson, M.D.: Professor at Chicago Medical School, J.D. and MPH from Harvard; board certified in allergy and immunology; in addition to numerous awards, helps AMA develop procedural terminology in areas of allergy and immunology
- Jack Arbiser, MD, PhD: Professor of Dermatology, the Winship Cancer Institute of Emory University; clinical researcher in skin cancer; MD and PhD from Harvard Medical School; member, American Academy of Dermatology and Society of Investigative Dermatology